These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8269531

  • 21. Inflammatory bowel disease in children 5 years of age and younger.
    Mamula P, Telega GW, Markowitz JE, Brown KA, Russo PA, Piccoli DA, Baldassano RN.
    Am J Gastroenterol; 2002 Aug; 97(8):2005-10. PubMed ID: 12190168
    [Abstract] [Full Text] [Related]

  • 22. Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins.
    Terjung B, Herzog V, Worman HJ, Gestmann I, Bauer C, Sauerbruch T, Spengler U.
    Hepatology; 1998 Aug; 28(2):332-40. PubMed ID: 9695994
    [Abstract] [Full Text] [Related]

  • 23. [Skin manifestations of pediatric inflammatory bowel disease].
    Martín de Carpi J, Chávez Caraza K, Vicente Villa MA, González Enseñat MA, Vilar Escrigas P, Vila Miravet V, Guallarte Alias P, Varea Calderón V.
    An Pediatr (Barc); 2009 Jun; 70(6):570-7. PubMed ID: 19446510
    [Abstract] [Full Text] [Related]

  • 24. [Carbonyl groups content in serum proteins as an indicator of disease activity in children with inflammatory bowel diseases and its dependence on the other markers of inflammatory process].
    Krzesiek E, Pytrus T, Kosmowska A, Iwańczak B.
    Pol Merkur Lekarski; 2008 Dec; 25(150):455-9. PubMed ID: 19205373
    [Abstract] [Full Text] [Related]

  • 25. Mortality and causes of death in patients with chronic inflammatory bowel disease in Gijón, Asturias (Spain).
    Saro Gismera C, Lacort Fernández M, Argüelles Fernández G, Antón Magarzo JL, Suárez González A, García López R, Navascués CA, Díaz Alvarez G, González Bernal A.
    Rev Esp Enferm Dig; 1999 Mar; 91(3):199-208. PubMed ID: 10231311
    [Abstract] [Full Text] [Related]

  • 26. Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.
    Kołtan S, Wysocki M, Kołtan A, Swiatkiewicz V, Styczyński J, Debski R, Balcar-Boroń A.
    Med Sci Monit; 2002 Apr; 8(4):CR274-9. PubMed ID: 11951070
    [Abstract] [Full Text] [Related]

  • 27. [New forms of hepatobiliary complications in chronic intestinal inflammatory disease].
    García-Paredes J, López-Nava G.
    Rev Esp Enferm Dig; 2000 Feb; 92(2):65-7. PubMed ID: 10798851
    [No Abstract] [Full Text] [Related]

  • 28. [Distinct clinical characteristics of inflammatory bowel disease in children younger than 5 years].
    Iwańczak B, Kofla-Dłubacz A, Mowszet K, Pytrus T, Krzesiek E, Iwańzak F.
    Pol Merkur Lekarski; 2008 Aug; 25(146):132-6. PubMed ID: 18942331
    [Abstract] [Full Text] [Related]

  • 29. Paediatric inflammatory bowel disease in New Zealand.
    Yap J, Wesley A, Mouat S, Chin S.
    N Z Med J; 2008 Oct 03; 121(1283):19-34. PubMed ID: 18841182
    [Abstract] [Full Text] [Related]

  • 30. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R.
    Mod Pathol; 2003 Apr 03; 16(4):347-58. PubMed ID: 12692200
    [Abstract] [Full Text] [Related]

  • 31. Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases.
    Newby EA, Croft NM, Green M, Hassan K, Heuschkel RB, Jenkins H, Casson DH.
    J Pediatr Gastroenterol Nutr; 2008 May 03; 46(5):539-45. PubMed ID: 18493209
    [Abstract] [Full Text] [Related]

  • 32. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 03; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 33. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S, Florin TH, Khalil D, Zhang MF, Patel K, Hamilton I, Hart DN.
    Am J Gastroenterol; 2001 Oct 03; 96(10):2946-56. PubMed ID: 11693331
    [Abstract] [Full Text] [Related]

  • 34. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
    Mielants H, Veys EM.
    Verh K Acad Geneeskd Belg; 1996 Oct 03; 58(2):93-116. PubMed ID: 8768479
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of chronic hepatitis with interferon in children with kidney diseases].
    Szczepańska M, Tobis A, Schneiberg B, Szprynger K, Kobos E, Morawiec-Knysak A.
    Pol Merkur Lekarski; 2005 Jan 03; 18(103):22-8. PubMed ID: 15859541
    [Abstract] [Full Text] [Related]

  • 36. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease.
    Marks DJ, Miyagi K, Rahman FZ, Novelli M, Bloom SL, Segal AW.
    Am J Gastroenterol; 2009 Jan 03; 104(1):117-24. PubMed ID: 19098859
    [Abstract] [Full Text] [Related]

  • 37. [Inflammatory bowel diseases in children].
    Langholz E, Munkholm P, Krasilnikoff PA, Binder V.
    Ugeskr Laeger; 1998 Sep 21; 160(39):5648-54. PubMed ID: 9771057
    [Abstract] [Full Text] [Related]

  • 38. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul 21; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 39. [Hepatitis caused by tick-borne meningoencephalitis virus (TBEV)--a rare clinical manifestation outside the central nervous system involvement].
    Misić-Majerus L, Bujić N, Madarić V, Avsić-Zupanc T.
    Acta Med Croatica; 2005 Jul 21; 59(4):347-52. PubMed ID: 16334744
    [Abstract] [Full Text] [Related]

  • 40. [Extra-intestinal manifestations].
    Descos L.
    Rev Prat; 1991 Feb 11; 41(5):415-8. PubMed ID: 2011689
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.